Fang Y. Sun

MSD R&D Co, Ltd
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Phase I open-label study of the respiratory syncytial virus monoclonal antibody clesrovimab: Safety and tolerability in healthy Chinese participants.

Phase I open-label study of the respiratory syncytial virus monoclonal antibody clesrovimab: Safety and tolerability in healthy Chinese participants.

Journal: Human vaccines & immunotherapeutics
Published: July 17, 2025

GNLY+CD8+ T cells bridge premature aging and persistent inflammation in people living with HIV.

GNLY+CD8+ T cells bridge premature aging and persistent inflammation in people living with HIV.

Journal: Emerging microbes & infections
Published: March 26, 2025

Three-dimensional genome architecture in intrahepatic cholangiocarcinoma.

Three-dimensional genome architecture in intrahepatic cholangiocarcinoma.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 19, 2024

Construction of near-infrared gradient hydrogel actuators using self-floating induction and LED photopolymerization.

Construction of near-infrared gradient hydrogel actuators using self-floating induction and LED photopolymerization.

Journal: Journal of colloid and interface science
Published: October 29, 2024

Construction of gradient ionogels by self-floatable hyperbranched organosilicon crosslinkers for multi-sensing and wirelessly monitoring physiological signals.

Construction of gradient ionogels by self-floatable hyperbranched organosilicon crosslinkers for multi-sensing and wirelessly monitoring physiological signals.

Journal: Journal of colloid and interface science
Published: July 01, 2024

Combination Immunotherapy of Oncolytic Flu-Vectored Virus and Programmed Cell Death 1 Blockade Enhances Antitumor Activity in Hepatocellular Carcinoma.

Combination Immunotherapy of Oncolytic Flu-Vectored Virus and Programmed Cell Death 1 Blockade Enhances Antitumor Activity in Hepatocellular Carcinoma.

Journal: Human gene therapy
Published: February 22, 2024

The Predictive Value of Atherogenic Index of Plasma, Non- High Density Lipoprotein Cholesterol (Non-HDL-C), Non-HDL-C/HDL-C, and Lipoprotein Combine Index for Stroke Incidence and Prognosis in Maintenance Hemodialysis Patients.

The Predictive Value of Atherogenic Index of Plasma, Non- High Density Lipoprotein Cholesterol (Non-HDL-C), Non-HDL-C/HDL-C, and Lipoprotein Combine Index for Stroke Incidence and Prognosis in Maintenance Hemodialysis Patients.

Journal: Clinical interventions in aging
Published: January 24, 2024

Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection.

Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection.

Journal: Antiviral research
Published: January 18, 2024

Retraction: Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma.

Retraction: Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma.

Journal: Oncotarget
Published: January 16, 2024

Protective efficacy of a novel recombinant influenza virus carrying partial human metapneumovirus F protein epitopes.

Protective efficacy of a novel recombinant influenza virus carrying partial human metapneumovirus F protein epitopes.

Journal: Virulence
Published: November 17, 2023

Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma.

Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma.

Journal: International immunopharmacology
Published: September 25, 2023

A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response.

A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response.

Journal: Human gene therapy
Published: August 30, 2023
Showing 1-12 of 38

Last Updated: 09/26/2026